HERC2 and neoplasm: HERC2 is an E3 ubiquitin ligase that regulates ubiquitin-dependent degradation of DNA repair proteins including BRCA1, and was an expression outlier in our patient’s tumor, further supporting therapeutic targeting of this pathway which ultimately was not pursued38.